Zobrazeno 1 - 10
of 247
pro vyhledávání: '"David S. Snyder"'
Autor:
Elisabeth Oppliger Leibundgut, Monika Haubitz, Bart Burington, Oliver G. Ottmann, Gary Spitzer, Olatoyosi Odenike, Michael A. McDevitt, Alexander Röth, David S. Snyder, Gabriela M. Baerlocher
Publikováno v:
Haematologica, Vol 106, Iss 9 (2020)
In a phase-2 study, the telomerase inhibitor imetelstat induced rapid hematologic responses in all patients with essential thrombocythemia who were refractory or intolerant to prior therapies. Significant molecular responses were achieved within 3-6
Externí odkaz:
https://doaj.org/article/43c8a3ad977a49d995ade2d9c11aaebf
Autor:
Timothy P. Hughes, Pierre Laneuville, Philippe Rousselot, David S. Snyder, Delphine Rea, Neil P. Shah, David Paar, Elisabetta Abruzzese, Andreas Hochhaus, Jeffrey H. Lipton, Jorge E. Cortes
Publikováno v:
Haematologica, Vol 104, Iss 1 (2019)
Dasatinib, a second-generation BCR-ABL1 tyrosine kinase inhibitor, is approved for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia, both as first-line therapy and after imatinib intolerance
Externí odkaz:
https://doaj.org/article/ec4e47fa4ec947b39d7674db85f6b7e9
Publikováno v:
Case Reports in Infectious Diseases, Vol 2019 (2019)
A 69-year-old immunocompromised man developed mitral valve endocarditis due to Salmonella enterica serotype Mbandaka, contracted from the cereal outbreak. The patient had a history of HLA-matched related hematopoietic stem cell transplant with persis
Externí odkaz:
https://doaj.org/article/a638f789ed9744f2afef419db1505d84
Autor:
Jorge Cortes, Moshe Talpaz, Hedy P. Smith, David S. Snyder, Jean Khoury, Kapil N. Bhalla, Javier Pinilla-Ibarz, Richard Larson, David Mitchell, Scott C. Wise, Thomas J. Rutkoski, Bryan D. Smith, Daniel L. Flynn, Hagop M. Kantarjian, Oliver Rosen, Richard A. Van Etten
Publikováno v:
Haematologica, Vol 102, Iss 3 (2017)
A vailable tyrosine kinase inhibitors for chronic myeloid leukemia bind in an adenosine 5′-triphosphate-binding pocket and are affected by evolving mutations that confer resistance. Rebastinib was identified as a switch control inhibitor of BCR-ABL
Externí odkaz:
https://doaj.org/article/1ddbfc9f06d74ca0ace93112fc0c45e7
Autor:
Tamer Othman, Ibrahim Aldoss, Ni-Chun Tsai, Hoda Pourhassan, Vaibhav Agrawal, Salman Otoukesh, Idoroenyi Amanam, Dat Ngo, Jason Chen, Monzr M. Al Malki, Amandeep Salhotra, Haris Ali, Ahmed Aribi, Karamjeet S. Sandhu, Shukaib Arslan, Brian J Ball, Forrest M. Stewart, Peter T. Curtin, Andrew S. Artz, David S Snyder, Guido Marcucci, Stephen J Forman, Anthony S. Stein, Ryotaro Nakamura, Vinod A. Pullarkat, Matthew Mei, Paul B. Koller
Publikováno v:
Blood. 140:10568-10570
Autor:
Paul Koller, Haoyue Shan, Joycelynne Palmer, Peter Curtin, Karamjeet S. Sandhu, Vaibhav Agrawal, Ricardo Spielberger, Joshua Mansour, Amanda Blackmon, Salman Otoukesh, Shukaib Arslan, Idoroenyi Amanam, Eileen Smith, Forrest Stewart, Brian Ball, Amandeep Salhotra, Ahmed Aribi, Ibrahim Aldoss, Andrew S. Artz, Anthony S. Stein, Guido Marcucci, Stephen J. Forman, Monzr M. Al Malki, Ryotaro Nakamura, David S Snyder, Haris Ali
Publikováno v:
Transplantation and Cellular Therapy. 29:S117-S118
Autor:
Tamer Othman, Paul Koller, Ni-Chun Tsai, Hoda Pourhassan, Vaibhav Agrawal, Salman Otoukesh, Idoroenyi Amanam, Dat Ngo, Jason Chen, Monzr M. Al Malki, Amandeep Salhotra, Haris Ali, Ahmed Aribi, Karamjeet S. Sandhu, Shukaib Arslan, Brian Ball, Forrest Stewart, Peter Curtin, Andrew S. Artz, David S Snyder, Guido Marcucci, Stephen J. Forman, Anthony S. Stein, Ryotaro Nakamura, Vinod Pullarkat, Ibrahim Aldoss, Matthew Mei
Publikováno v:
Blood. 140:12819-12820
Autor:
Paul B. Koller, Haoyue Shan, Joycelynne Palmer, Peter T. Curtin, Karamjeet S. Sandhu, Vaibhav Agrawal, Ricardo Spielberger, Joshua Mansour, Amanda Blackmon, Salman Otoukesh, Shukaib Arslan, Idoroenyi Amanam, Eileen P. Smith, Forrest M. Stewart, Brian J Ball, Amandeep Salhotra, Ahmed Aribi, Ibrahim Aldoss, Vinod A. Pullarkat, Anthony S. Stein, Andrew S. Artz, Guido Marcucci, Stephen J Forman, Ryotaro Nakamura, Monzr M. Al Malki, David S Snyder, Haris Ali
Publikováno v:
Blood. 140:12945-12946
Autor:
Stephen J. Forman, Haris Ali, David S. Snyder, Amandeep Salhotra, Ahmed Aribi, Anthony S. Stein, Ryotaro Nakamura, Sanjeet Dadwal, Dongyun Yang, Karamjeet S. Sandhu, Samer K. Khaled, Guido Marcucci, Monzr M. Al Malki, Joycelynne Palmer, Matthew Mei, Ibrahim Aldoss, Vinod Pullarkat
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:e322-e327
The combination of hypomethylating agents with the selective Bcl-2 inhibitor venetoclax (HMA-VEN) has emerged as a highly active regimen in patients with acute myelogenous leukemia (AML) in both the upfront and relapsed/refractory (r/r) settings. We
Autor:
B. Douglas Smith, Monica Mead, Michal G. Rose, Jessica K. Altman, Leland Metheny, Ravi Bhatia, Michael W. Deininger, Mrinal M. Patnaik, Moshe Talpaz, Joseph O. Moore, Kendra Sweet, Kiran Naqvi, Lori J. Maness, Arnel Pallera, Sanjay R. Mohan, Gabriela S. Hobbs, Bhavana Bhatnagar, James E. Thompson, Daniel J. DeAngelo, Kristina M. Gregory, Keith W. Pratz, David T. Yang, Ellin Berman, Neil P. Shah, Hema Sundar, David S. Snyder, Jason Gotlib, Iskra Pusic, Vivian G. Oehler
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:1385-1415
Chronic myeloid leukemia (CML) is defined by the presence of Philadelphia chromosome (Ph) which results from a reciprocal translocation between chromosomes 9 and 22 [t(9;22] that gives rise to aBCR-ABL1fusion gene. CML occurs in 3 different phases (c